peptide t has been researched along with EBV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, M; Amann, K; Bruns, H; Büttner-Herold, M; Gary, R; Gerbitz, A; Hennig, S; Hummel, M; Lammoglia Cobo, MF; Mackensen, A; Mautner, J; Moi, S; Moosmann, A; Ritter, J; Rösler, W; Schaffer, S; Seegebarth, A; Seitz, V; Völkl, S | 1 |
1 other study(ies) available for peptide t and EBV Infections
| Article | Year |
|---|---|
Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.
Topics: Adoptive Transfer; Epitopes; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Peptide T; Peptides; T-Lymphocytes | 2022 |